-
(
Ter VeerE
Haj MohammadN
van ValkenhoefG
, et al. The efficacy and safety of first-line chemotherapy in advanced esophagogastric cancer: a network meta-analysis. J Natl Cancer Inst
2016; 108: djw166.)
Ter VeerE
Haj MohammadN
van ValkenhoefG
, et al. The efficacy and safety of first-line chemotherapy in advanced esophagogastric cancer: a network meta-analysis. J Natl Cancer Inst
2016; 108: djw166.
Ter VeerE
Haj MohammadN
van ValkenhoefG
, et al. The efficacy and safety of first-line chemotherapy in advanced esophagogastric cancer: a network meta-analysis. J Natl Cancer Inst
2016; 108: djw166.,
Ter VeerE
Haj MohammadN
van ValkenhoefG
, et al. The efficacy and safety of first-line chemotherapy in advanced esophagogastric cancer: a network meta-analysis. J Natl Cancer Inst
2016; 108: djw166.
-
E.
Smyth,
M.
Verheij,
W.
Allum,
D.
Cunningham,
A.
Cervantes,
D.
Arnold
(2022)
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology, 27 suppl 5
-
(
NapierKJ
ScheererM
MisraS
. Esophageal cancer: a review of epidemiology, pathogenesis, staging workup and treatment modalities. World J Gastrointest Oncol
2014; 6: 112–120.24834141)
NapierKJ
ScheererM
MisraS
. Esophageal cancer: a review of epidemiology, pathogenesis, staging workup and treatment modalities. World J Gastrointest Oncol
2014; 6: 112–120.24834141
NapierKJ
ScheererM
MisraS
. Esophageal cancer: a review of epidemiology, pathogenesis, staging workup and treatment modalities. World J Gastrointest Oncol
2014; 6: 112–120.24834141,
NapierKJ
ScheererM
MisraS
. Esophageal cancer: a review of epidemiology, pathogenesis, staging workup and treatment modalities. World J Gastrointest Oncol
2014; 6: 112–120.24834141
-
(
International Union against Cancer (UICC). TNM classification of malignant tumours. 8th ed.
Chichester: Wiley-Blackwell, 2017.)
International Union against Cancer (UICC). TNM classification of malignant tumours. 8th ed.
Chichester: Wiley-Blackwell, 2017.
International Union against Cancer (UICC). TNM classification of malignant tumours. 8th ed.
Chichester: Wiley-Blackwell, 2017.,
International Union against Cancer (UICC). TNM classification of malignant tumours. 8th ed.
Chichester: Wiley-Blackwell, 2017.
-
(
SungH
FerlayJ
SiegelRL
, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin
2021; 71: 209–249.33538338)
SungH
FerlayJ
SiegelRL
, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin
2021; 71: 209–249.33538338
SungH
FerlayJ
SiegelRL
, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin
2021; 71: 209–249.33538338,
SungH
FerlayJ
SiegelRL
, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin
2021; 71: 209–249.33538338
-
(
Haj MohammadN
BernardsN
van PuttenM
, et al. Volume-outcome relation in palliative systemic treatment of metastatic oesophagogastric cancer. Eur J Cancer
2017; 78: 28–36.28412586)
Haj MohammadN
BernardsN
van PuttenM
, et al. Volume-outcome relation in palliative systemic treatment of metastatic oesophagogastric cancer. Eur J Cancer
2017; 78: 28–36.28412586
Haj MohammadN
BernardsN
van PuttenM
, et al. Volume-outcome relation in palliative systemic treatment of metastatic oesophagogastric cancer. Eur J Cancer
2017; 78: 28–36.28412586,
Haj MohammadN
BernardsN
van PuttenM
, et al. Volume-outcome relation in palliative systemic treatment of metastatic oesophagogastric cancer. Eur J Cancer
2017; 78: 28–36.28412586
-
Management and outcomes of gastric cancer patients with interval distant metastases in clinical practice
-
E.
Ebbing,
A.
Zalm,
Anne
Steins,
A.
Creemers,
Simone
Hermsen,
Rosa
Rentenaar,
M.
Klein,
C.
Waasdorp,
G.
Hooijer,
S.
Meijer,
K.
Krishnadath,
C.
Punt,
M.
Henegouwen,
S.
Gisbertz,
O.
Delden,
M.
Hulshof,
J.
Medema,
H.
Laarhoven,
M.
Bijlsma
(2019)
Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma
Proceedings of the National Academy of Sciences of the United States of America, 116
-
(
EbbingEA
van der ZalmAP
SteinsA
, et al. Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma. Proc Natl Acad Sci USA
2019; 116: 2237–2242.30670657)
EbbingEA
van der ZalmAP
SteinsA
, et al. Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma. Proc Natl Acad Sci USA
2019; 116: 2237–2242.30670657
EbbingEA
van der ZalmAP
SteinsA
, et al. Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma. Proc Natl Acad Sci USA
2019; 116: 2237–2242.30670657,
EbbingEA
van der ZalmAP
SteinsA
, et al. Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma. Proc Natl Acad Sci USA
2019; 116: 2237–2242.30670657
-
E.
Ebbing,
Anne
Steins,
E.
Fessler,
P.
Stathi,
W.
Lesterhuis,
K.
Krishnadath,
L.
Vermeulen,
J.
Medema,
M.
Bijlsma,
H.
Laarhoven
(2017)
Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition.
Gastroenterology, 153 1
-
(
Dutch clinical practice guidelines for esophageal carcinoma – follow-up, 2010, www.richtlijnendatabase.nl (accessed March 2021).)
Dutch clinical practice guidelines for esophageal carcinoma – follow-up, 2010, www.richtlijnendatabase.nl (accessed March 2021).
Dutch clinical practice guidelines for esophageal carcinoma – follow-up, 2010, www.richtlijnendatabase.nl (accessed March 2021).,
Dutch clinical practice guidelines for esophageal carcinoma – follow-up, 2010, www.richtlijnendatabase.nl (accessed March 2021).
-
Anne
Steins,
E.
Ebbing,
A.
Creemers,
A.
Zalm,
R.
Jibodh,
C.
Waasdorp,
S.
Meijer,
O.
Delden,
K.
Krishnadath,
M.
Hulshof,
R.
Bennink,
C.
Punt,
J.
Medema,
M.
Bijlsma,
H.
Laarhoven
(2019)
Chemoradiation induces epithelial‐to‐mesenchymal transition in esophageal adenocarcinoma
International Journal of Cancer, 145
-
E.
Veer,
N.
Mohammad,
G.
Valkenhoef,
L.
Ngai,
R.
Mali,
M.
Anderegg,
M.
Oijen,
H.
Laarhoven
(2016)
The Efficacy and Safety of First-line Chemotherapy in Advanced Esophagogastric Cancer: A Network Meta-analysis.
Journal of the National Cancer Institute, 108 10
-
Kyle
Napier,
Mary
Scheerer,
S.
Misra
(2014)
Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities.
World journal of gastrointestinal oncology, 6 5
-
W.
Dijksterhuis,
R.
Verhoeven,
M.
Pape,
M.
Slingerland,
N.
Mohammad,
J.
Vos-Geelen,
L.
Beerepoot,
T.
Voorthuizen,
G.
Creemers,
V.
Lemmens,
M.
Oijen,
H.
Laarhoven
(2020)
Hospital volume and beyond first-line palliative systemic treatment in metastatic oesophagogastric adenocarcinoma: A population-based study.
European journal of cancer, 139
-
R.
Adam,
A.
Gramont,
J.
Figueras,
N.
Kokudo,
F.
Kunstlinger,
E.
Loyer,
G.
Poston,
P.
Rougier,
L.
Rubbia-Brandt,
A.
Sobrero,
C.
Teh,
S.
Tejpar,
E.
Cutsem,
J.
Vauthey,
L.
Påhlman
(2015)
Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus.
Cancer treatment reviews, 41 9
-
(
Dutch clinical practice guidelines for gastric carcinoma – follow-up version 2.2, www.richtlijnendatabase.nl (accessed June 2021).)
Dutch clinical practice guidelines for gastric carcinoma – follow-up version 2.2, www.richtlijnendatabase.nl (accessed June 2021).
Dutch clinical practice guidelines for gastric carcinoma – follow-up version 2.2, www.richtlijnendatabase.nl (accessed June 2021).,
Dutch clinical practice guidelines for gastric carcinoma – follow-up version 2.2, www.richtlijnendatabase.nl (accessed June 2021).
-
(
KellyRJ
KuzdzalJ
ZanderT
, et al. Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer following neoadjuvant chemoradiation therapy: first results of the CheckMate 577 study. ESMO Virtual Congress
2020; 31: S1142–S1215.)
KellyRJ
KuzdzalJ
ZanderT
, et al. Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer following neoadjuvant chemoradiation therapy: first results of the CheckMate 577 study. ESMO Virtual Congress
2020; 31: S1142–S1215.
KellyRJ
KuzdzalJ
ZanderT
, et al. Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer following neoadjuvant chemoradiation therapy: first results of the CheckMate 577 study. ESMO Virtual Congress
2020; 31: S1142–S1215.,
KellyRJ
KuzdzalJ
ZanderT
, et al. Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer following neoadjuvant chemoradiation therapy: first results of the CheckMate 577 study. ESMO Virtual Congress
2020; 31: S1142–S1215.
-
A.
Carmona-Bayonas,
P.
Jiménez-Fonseca,
A.
Custodio,
M.
Cánovas,
R.
Hernandez,
C.
Pericay,
I.
Echavarria,
A.
Lacalle,
L.
Visa,
A.
Palomo,
M.
Mangas,
J.
Cano,
E.
Buxó,
F.
Alvarez-Manceñido,
T.
García,
J.
Lorenzo,
M.
Ferrer-Cardona,
A.
Viúdez,
A.
Azkárate,
A.
Ramchandani,
D.
Arias,
F.
Longo,
C.
Lopez,
R.
Bayona,
M.
Limón,
A.
Díaz‐Serrano,
A.
Montes,
P.
Sala,
P.
Cerda,
F.
Rivera,
J.
Gallego,
Agamenon
group
(2017)
Anthracycline-based triplets do not improve the efficacy of platinum-fluoropyrimidine doublets in first-line treatment of advanced gastric cancer: real-world data from the AGAMEMON National Cancer Registry
Gastric Cancer, 21
-
V.
Väyrynen,
E.
Wirta,
Toni
Seppälä,
Toni
Seppälä,
E.
Sihvo,
J.
Mecklin,
K.
Vasala,
I.
Kellokumpu
(2020)
Incidence and management of patients with colorectal cancer and synchronous and metachronous colorectal metastases: a population‐based study
BJS Open, 4
-
R.
Kelly,
J.
Ajani,
J.
Kużdżał,
T.
Zander,
E.
Cutsem,
G.
Piessen,
G.
Mendez,
J.
Feliciano,
S.
Motoyama,
A.
Lièvre,
H.
Uronis,
E.
Elimova,
C.
Grootscholten,
K.
Geboes,
S.
Zafar,
S.
Snow,
A.
Ko,
K.
Feeney,
M.
Schenker,
Piotr
Kocoń,
Jenny
Zhang,
Lili
Zhu,
M.
Lei,
Prianka
Singh,
K.
Kondo,
J.
Cleary,
M.
Moehler
(2021)
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.
The New England journal of medicine, 384 13
-
(2020)
Quality of life during palliative systemic therapy for esophagogastric cancer: systematic review and meta-analysis
-
T.
Kroese,
W.
Dijksterhuis,
P.
Rossum,
R.
Verhoeven,
S.
Mook,
N.
Mohammad,
M.
Hulshof,
M.
Henegouwen,
M.
Oijen,
J.
Ruurda,
H.
Laarhoven,
R.
Hillegersberg
(2021)
Prognosis of interval distant metastases after neoadjuvant chemoradiotherapy for esophageal cancer.
The Annals of thoracic surgery
-
(
ClaassenYHM
BastiaannetE
HartgrinkHH
, et al. International comparison of treatment strategy and survival in metastatic gastric cancer. BJS Open
2019; 3: 56–61.30734016)
ClaassenYHM
BastiaannetE
HartgrinkHH
, et al. International comparison of treatment strategy and survival in metastatic gastric cancer. BJS Open
2019; 3: 56–61.30734016
ClaassenYHM
BastiaannetE
HartgrinkHH
, et al. International comparison of treatment strategy and survival in metastatic gastric cancer. BJS Open
2019; 3: 56–61.30734016,
ClaassenYHM
BastiaannetE
HartgrinkHH
, et al. International comparison of treatment strategy and survival in metastatic gastric cancer. BJS Open
2019; 3: 56–61.30734016
-
J.
Opstelten,
L.
Wijkerslooth,
M.
Leenders,
D.
Bac,
M.
Brink,
B.
Loffeld,
Mariëlle
Meijnen-Bult,
I.
Minderhoud,
M.
Verhagen,
M.
Oijen,
P.
Siersema
(2016)
Variation in palliative care of esophageal cancer in clinical practice: factors associated with treatment decisions.
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 30 2
-
(
OpsteltenJL
de WijkersloothLR
LeendersM
, et al. Variation in palliative care of esophageal cancer in clinical practice: factors associated with treatment decisions. Dis Esophagus
2017; 30: 1–7.)
OpsteltenJL
de WijkersloothLR
LeendersM
, et al. Variation in palliative care of esophageal cancer in clinical practice: factors associated with treatment decisions. Dis Esophagus
2017; 30: 1–7.
OpsteltenJL
de WijkersloothLR
LeendersM
, et al. Variation in palliative care of esophageal cancer in clinical practice: factors associated with treatment decisions. Dis Esophagus
2017; 30: 1–7.,
OpsteltenJL
de WijkersloothLR
LeendersM
, et al. Variation in palliative care of esophageal cancer in clinical practice: factors associated with treatment decisions. Dis Esophagus
2017; 30: 1–7.
-
A.
Carmona-Bayonas,
P.
Jiménez-Fonseca,
R.
Hernandez,
A.
Custodio,
J.
Cano,
A.
Lacalle,
I.
Diaz-Guardamino,
I.
Macías,
M.
Izquierdo,
L.
Visa,
E.
Orra,
A.
Azkárate,
A.
Vaswani,
E.
Castro,
A.
Montes,
F.
Longo,
R.
Bayona,
M.
Limón,
A.
Carnicero,
J.
Plazas
(2017)
677PTreatment of advanced gastric cancer based on Lauren’s histological: Real-world data from the AGAMEMON National Cancer Registry
Annals of Oncology, 28
-
Zai
Luo,
Zeyin
Rong,
Chen
Huang
(2019)
Surgery Strategies for Gastric Cancer With Liver Metastasis
Frontiers in Oncology, 9
-
W.
Dijksterhuis,
R.
Verhoeven,
M.
Slingerland,
N.
Mohammad,
J.
Vos-Geelen,
L.
Beerepoot,
T.
Voorthuizen,
G.
Creemers,
M.
Oijen,
H.
Laarhoven
(2019)
Heterogeneity of first‐line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: A real‐world evidence study
International Journal of Cancer, 146
-
(
DijksterhuisWPM
VerhoevenRHA
PapeM
, et al. Hospital volume and beyond first-line palliative systemic treatment in metastatic oesophagogastric adenocarcinoma: a population-based study. Eur J Cancer
2020; 139: 107–118.32980749)
DijksterhuisWPM
VerhoevenRHA
PapeM
, et al. Hospital volume and beyond first-line palliative systemic treatment in metastatic oesophagogastric adenocarcinoma: a population-based study. Eur J Cancer
2020; 139: 107–118.32980749
DijksterhuisWPM
VerhoevenRHA
PapeM
, et al. Hospital volume and beyond first-line palliative systemic treatment in metastatic oesophagogastric adenocarcinoma: a population-based study. Eur J Cancer
2020; 139: 107–118.32980749,
DijksterhuisWPM
VerhoevenRHA
PapeM
, et al. Hospital volume and beyond first-line palliative systemic treatment in metastatic oesophagogastric adenocarcinoma: a population-based study. Eur J Cancer
2020; 139: 107–118.32980749
-
Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer following neoadjuvant chemoradiation therapy: first results of the CheckMate 577 study
-
M.
Riihimäki,
A.
Hemminki,
K.
Sundquist,
J.
Sundquist,
K.
Hemminki
(2016)
Metastatic spread in patients with gastric cancer
Oncotarget, 7
-
(
SmythEC
VerheijM
AllumW
, et al. Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol
2016; 27: v38–v49.27664260)
SmythEC
VerheijM
AllumW
, et al. Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol
2016; 27: v38–v49.27664260
SmythEC
VerheijM
AllumW
, et al. Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol
2016; 27: v38–v49.27664260,
SmythEC
VerheijM
AllumW
, et al. Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol
2016; 27: v38–v49.27664260
-
(
van PuttenM
de Vos-GeelenJ
NieuwenhuijzenGAP
, et al. Long-term survival improvement in oesophageal cancer in the Netherlands. Eur J Cancer
2018; 94: 138–147.29571082)
van PuttenM
de Vos-GeelenJ
NieuwenhuijzenGAP
, et al. Long-term survival improvement in oesophageal cancer in the Netherlands. Eur J Cancer
2018; 94: 138–147.29571082
van PuttenM
de Vos-GeelenJ
NieuwenhuijzenGAP
, et al. Long-term survival improvement in oesophageal cancer in the Netherlands. Eur J Cancer
2018; 94: 138–147.29571082,
van PuttenM
de Vos-GeelenJ
NieuwenhuijzenGAP
, et al. Long-term survival improvement in oesophageal cancer in the Netherlands. Eur J Cancer
2018; 94: 138–147.29571082
-
(
LordickF
MarietteC
HaustermansK
, et al. Oesophageal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol
2016; 27: v50–v57.27664261)
LordickF
MarietteC
HaustermansK
, et al. Oesophageal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol
2016; 27: v50–v57.27664261
LordickF
MarietteC
HaustermansK
, et al. Oesophageal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol
2016; 27: v50–v57.27664261,
LordickF
MarietteC
HaustermansK
, et al. Oesophageal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol
2016; 27: v50–v57.27664261
-
B.
Turner
(2019)
International Union Against Cancer (UICC)
B-Model Gromov-Witten Theory
-
H.
Sung,
J.
Ferlay,
R.
Siegel,
M.
Laversanne,
I.
Soerjomataram,
A.
Jemal,
F.
Bray
(2021)
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
CA: A Cancer Journal for Clinicians, 71
-
(
AdamR
de GramontA
FiguerasJ
, et al. Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. Cancer Treat Rev
2015; 41: 729–741.26417845)
AdamR
de GramontA
FiguerasJ
, et al. Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. Cancer Treat Rev
2015; 41: 729–741.26417845
AdamR
de GramontA
FiguerasJ
, et al. Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. Cancer Treat Rev
2015; 41: 729–741.26417845,
AdamR
de GramontA
FiguerasJ
, et al. Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. Cancer Treat Rev
2015; 41: 729–741.26417845
-
Y.
Claassen,
E.
Bastiaannet,
H.
Hartgrink,
J.
Dikken,
W.
Steur,
M.
Slingerland,
R.
Verhoeven,
E.
Eycken,
H.
Schutter,
M.
Lindblad,
J.
Hedberg,
Egil
Johnson,
G.
Hjortland,
L.
Jensen,
H.
Larsson,
T.
Koessler,
M.
Chevallay,
W.
Allum,
C.
Velde
(2018)
International comparison of treatment strategy and survival in metastatic gastric cancer
BJS Open, 3
-
(
ThelenA
JonasS
BenckertC
, et al. Liver resection for metastatic gastric cancer. Eur J Surg Oncol
2008; 34: 1328–1334.18329229)
ThelenA
JonasS
BenckertC
, et al. Liver resection for metastatic gastric cancer. Eur J Surg Oncol
2008; 34: 1328–1334.18329229
ThelenA
JonasS
BenckertC
, et al. Liver resection for metastatic gastric cancer. Eur J Surg Oncol
2008; 34: 1328–1334.18329229,
ThelenA
JonasS
BenckertC
, et al. Liver resection for metastatic gastric cancer. Eur J Surg Oncol
2008; 34: 1328–1334.18329229
-
M.
Putten,
J.
Vos-Geelen,
G.
Nieuwenhuijzen,
P.
Siersema,
V.
Lemmens,
C.
Rosman,
M.
Sangen,
R.
Verhoeven
(2018)
Long-term survival improvement in oesophageal cancer in the Netherlands.
European journal of cancer, 94
-
(
VayrynenV
WirtaEV
SeppalaT
, et al. Incidence and management of patients with colorectal cancer and synchronous and metachronous colorectal metastases: a population-based study. BJS Open
2020; 4: 685–692.32543788)
VayrynenV
WirtaEV
SeppalaT
, et al. Incidence and management of patients with colorectal cancer and synchronous and metachronous colorectal metastases: a population-based study. BJS Open
2020; 4: 685–692.32543788
VayrynenV
WirtaEV
SeppalaT
, et al. Incidence and management of patients with colorectal cancer and synchronous and metachronous colorectal metastases: a population-based study. BJS Open
2020; 4: 685–692.32543788,
VayrynenV
WirtaEV
SeppalaT
, et al. Incidence and management of patients with colorectal cancer and synchronous and metachronous colorectal metastases: a population-based study. BJS Open
2020; 4: 685–692.32543788
-
N.
Mohammad,
N.
Bernards,
M.
Putten,
V.
Lemmens,
M.
Oijen,
H.
Laarhoven
(2017)
Volume-outcome relation in palliative systemic treatment of metastatic oesophagogastric cancer.
European journal of cancer, 78
-
Florian
Lordick,
C.
Mariette,
K.
Haustermans,
R.
Obermannova,
D.
Arnold
(2013)
Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology, 24 Suppl 6
-
A.
Wagner,
W.
Grothe,
J.
Haerting,
G.
Kleber,
A.
Grothey,
W.
Fleig
(2006)
Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 18
-
(
van KleefJJ
Ter VeerE
van den BoornHG
, et al. Quality of life during palliative systemic therapy for esophagogastric cancer: systematic review and meta-analysis. J Natl Cancer Inst
2020; 112: 12–29.31251346)
van KleefJJ
Ter VeerE
van den BoornHG
, et al. Quality of life during palliative systemic therapy for esophagogastric cancer: systematic review and meta-analysis. J Natl Cancer Inst
2020; 112: 12–29.31251346
van KleefJJ
Ter VeerE
van den BoornHG
, et al. Quality of life during palliative systemic therapy for esophagogastric cancer: systematic review and meta-analysis. J Natl Cancer Inst
2020; 112: 12–29.31251346,
van KleefJJ
Ter VeerE
van den BoornHG
, et al. Quality of life during palliative systemic therapy for esophagogastric cancer: systematic review and meta-analysis. J Natl Cancer Inst
2020; 112: 12–29.31251346
-
(
SteinsA
EbbingEA
CreemersA
, et al. Chemoradiation induces epithelial-to-mesenchymal transition in esophageal adenocarcinoma. Int J Cancer
2019; 145: 2792–2803.31018252)
SteinsA
EbbingEA
CreemersA
, et al. Chemoradiation induces epithelial-to-mesenchymal transition in esophageal adenocarcinoma. Int J Cancer
2019; 145: 2792–2803.31018252
SteinsA
EbbingEA
CreemersA
, et al. Chemoradiation induces epithelial-to-mesenchymal transition in esophageal adenocarcinoma. Int J Cancer
2019; 145: 2792–2803.31018252,
SteinsA
EbbingEA
CreemersA
, et al. Chemoradiation induces epithelial-to-mesenchymal transition in esophageal adenocarcinoma. Int J Cancer
2019; 145: 2792–2803.31018252
-
A.
Thelen,
Sven
Jonas,
C.
Benckert,
E.
Lopez-Hänninen,
Ulf
Neumann,
Birgit
Rudolph,
Guido
Schumacher,
Peter
Neuhaus
(2008)
Liver resection for metastatic gastric cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 34 12
-
(
Dutch clinical practice guidelines for esophageal carcinoma version 31, 2015, www.oncoline.nl (accessed October 2020).)
Dutch clinical practice guidelines for esophageal carcinoma version 31, 2015, www.oncoline.nl (accessed October 2020).
Dutch clinical practice guidelines for esophageal carcinoma version 31, 2015, www.oncoline.nl (accessed October 2020).,
Dutch clinical practice guidelines for esophageal carcinoma version 31, 2015, www.oncoline.nl (accessed October 2020).
-
(
JeenePM
VersteijneE
van Berge HenegouwenMI
, et al. Supraclavicular node disease is not an independent prognostic factor for survival of esophageal cancer patients treated with definitive chemoradiation. Acta Oncol
2017; 56: 33–38.27842455)
JeenePM
VersteijneE
van Berge HenegouwenMI
, et al. Supraclavicular node disease is not an independent prognostic factor for survival of esophageal cancer patients treated with definitive chemoradiation. Acta Oncol
2017; 56: 33–38.27842455
JeenePM
VersteijneE
van Berge HenegouwenMI
, et al. Supraclavicular node disease is not an independent prognostic factor for survival of esophageal cancer patients treated with definitive chemoradiation. Acta Oncol
2017; 56: 33–38.27842455,
JeenePM
VersteijneE
van Berge HenegouwenMI
, et al. Supraclavicular node disease is not an independent prognostic factor for survival of esophageal cancer patients treated with definitive chemoradiation. Acta Oncol
2017; 56: 33–38.27842455
-
(
KroeseTE
DijksterhuisWPM
van RossumPSN
, et al. Prognosis of interval distant metastases after neoadjuvant chemoradiotherapy for esophageal cancer. Ann Thorac Surg
2022; 113: 482–490.33610543)
KroeseTE
DijksterhuisWPM
van RossumPSN
, et al. Prognosis of interval distant metastases after neoadjuvant chemoradiotherapy for esophageal cancer. Ann Thorac Surg
2022; 113: 482–490.33610543
KroeseTE
DijksterhuisWPM
van RossumPSN
, et al. Prognosis of interval distant metastases after neoadjuvant chemoradiotherapy for esophageal cancer. Ann Thorac Surg
2022; 113: 482–490.33610543,
KroeseTE
DijksterhuisWPM
van RossumPSN
, et al. Prognosis of interval distant metastases after neoadjuvant chemoradiotherapy for esophageal cancer. Ann Thorac Surg
2022; 113: 482–490.33610543
-
P.
Jeene,
E.
Versteijne,
M.
Henegouwen,
J.
Bergmann,
E.
Geijsen,
H.
Laarhoven,
M.
Hulshof
(2017)
Supraclavicular node disease is not an independent prognostic factor for survival of esophageal cancer patients treated with definitive chemoradiation
Acta Oncologica, 56
-
(
WagnerAD
GrotheW
HaertingJ
, et al. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol
2006; 24: 2903–2909.16782930)
WagnerAD
GrotheW
HaertingJ
, et al. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol
2006; 24: 2903–2909.16782930
WagnerAD
GrotheW
HaertingJ
, et al. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol
2006; 24: 2903–2909.16782930,
WagnerAD
GrotheW
HaertingJ
, et al. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol
2006; 24: 2903–2909.16782930
-
(
Carmona-BayonasA
Jimenez-FonsecaP
CustodioA
, et al. Anthracycline-based triplets do not improve the efficacy of platinum-fluoropyrimidine doublets in first-line treatment of advanced gastric cancer: real-world data from the AGAMEMON National Cancer Registry. Gastric Cancer
2018; 21: 96–105.28393278)
Carmona-BayonasA
Jimenez-FonsecaP
CustodioA
, et al. Anthracycline-based triplets do not improve the efficacy of platinum-fluoropyrimidine doublets in first-line treatment of advanced gastric cancer: real-world data from the AGAMEMON National Cancer Registry. Gastric Cancer
2018; 21: 96–105.28393278
Carmona-BayonasA
Jimenez-FonsecaP
CustodioA
, et al. Anthracycline-based triplets do not improve the efficacy of platinum-fluoropyrimidine doublets in first-line treatment of advanced gastric cancer: real-world data from the AGAMEMON National Cancer Registry. Gastric Cancer
2018; 21: 96–105.28393278,
Carmona-BayonasA
Jimenez-FonsecaP
CustodioA
, et al. Anthracycline-based triplets do not improve the efficacy of platinum-fluoropyrimidine doublets in first-line treatment of advanced gastric cancer: real-world data from the AGAMEMON National Cancer Registry. Gastric Cancer
2018; 21: 96–105.28393278
-
(
LuoZ
RongZ
HuangC
. Surgery strategies for gastric cancer with liver metastasis. Front Oncol
2019; 9: 1353.31921626)
LuoZ
RongZ
HuangC
. Surgery strategies for gastric cancer with liver metastasis. Front Oncol
2019; 9: 1353.31921626
LuoZ
RongZ
HuangC
. Surgery strategies for gastric cancer with liver metastasis. Front Oncol
2019; 9: 1353.31921626,
LuoZ
RongZ
HuangC
. Surgery strategies for gastric cancer with liver metastasis. Front Oncol
2019; 9: 1353.31921626
-
(
Dutch clinical practice guidelines for gastric carcinoma version 20, 2017, www.oncoline.nl (accessed October 2020).)
Dutch clinical practice guidelines for gastric carcinoma version 20, 2017, www.oncoline.nl (accessed October 2020).
Dutch clinical practice guidelines for gastric carcinoma version 20, 2017, www.oncoline.nl (accessed October 2020).,
Dutch clinical practice guidelines for gastric carcinoma version 20, 2017, www.oncoline.nl (accessed October 2020).
-
(
RiihimakiM
HemminkiA
SundquistK
, et al. Metastatic spread in patients with gastric cancer. Oncotarget
2016; 7: 52307–52316.27447571)
RiihimakiM
HemminkiA
SundquistK
, et al. Metastatic spread in patients with gastric cancer. Oncotarget
2016; 7: 52307–52316.27447571
RiihimakiM
HemminkiA
SundquistK
, et al. Metastatic spread in patients with gastric cancer. Oncotarget
2016; 7: 52307–52316.27447571,
RiihimakiM
HemminkiA
SundquistK
, et al. Metastatic spread in patients with gastric cancer. Oncotarget
2016; 7: 52307–52316.27447571
-
Dutch clinical practice guidelines for esophageal carcinoma version 31